GUERBET (GBT.PA) Fundamental Analysis & Valuation
EPA:GBT • FR0000032526
Current stock price
9.85 EUR
+0.19 (+1.97%)
Last:
This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GBT.PA Profitability Analysis
1.1 Basic Checks
- In the past year GBT has reported negative net income.
- In the past year GBT had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: GBT reported negative net income in multiple years.
- In the past 5 years GBT always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of GBT (-11.65%) is worse than 71.43% of its industry peers.
- Looking at the Return On Equity, with a value of -40.57%, GBT is doing worse than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROIC | N/A |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- In the last couple of years the Operating Margin of GBT has declined.
- With an excellent Gross Margin value of 75.59%, GBT belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
- In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for GBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% |
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
2. GBT.PA Health Analysis
2.1 Basic Checks
- GBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, GBT has about the same amount of shares outstanding.
- The number of shares outstanding for GBT remains at a similar level compared to 5 years ago.
- Compared to 1 year ago, GBT has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.58, we must say that GBT is in the distress zone and has some risk of bankruptcy.
- GBT has a worse Altman-Z score (1.58) than 68.25% of its industry peers.
- The Debt to FCF ratio of GBT is 9.84, which is on the high side as it means it would take GBT, 9.84 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of GBT (9.84) is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.47 is on the high side and indicates that GBT has dependencies on debt financing.
- The Debt to Equity ratio of GBT (1.47) is worse than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Altman-Z | 1.58 |
ROIC/WACCN/A
WACC6.02%
2.3 Liquidity
- GBT has a Current Ratio of 2.49. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
- GBT's Current ratio of 2.49 is fine compared to the rest of the industry. GBT outperforms 76.19% of its industry peers.
- A Quick Ratio of 1.27 indicates that GBT should not have too much problems paying its short term obligations.
- The Quick ratio of GBT (1.27) is better than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 |
3. GBT.PA Growth Analysis
3.1 Past
- The earnings per share for GBT have decreased strongly by -769.32% in the last year.
- GBT shows a decrease in Revenue. In the last year, the revenue decreased by -6.50%.
- Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 2.00% on average per year.
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
3.2 Future
- The Earnings Per Share is expected to grow by 100.64% on average over the next years. This is a very strong growth
- Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 1.03% on average per year.
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. GBT.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for GBT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 95.24% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.8 | ||
| EV/EBITDA | 4.77 |
4.3 Compensation for Growth
- GBT's earnings are expected to grow with 100.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y275.2%
EPS Next 3Y100.64%
5. GBT.PA Dividend Analysis
5.1 Amount
- GBT has a Yearly Dividend Yield of 2.69%.
- In the last 3 months the price of GBT has falen by -31.69%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- GBT's Dividend Yield is rather good when compared to the industry average which is at 1.23. GBT pays more dividend than 84.13% of the companies in the same industry.
- GBT's Dividend Yield is a higher than the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
GBT.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:GBT (4/17/2026, 7:00:00 PM)
9.85
+0.19 (+1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2026-03-11
Earnings (Next)04-23 2026-04-23
Inst Owners8.83%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap124.50M
Revenue(TTM)786.44M
Net Income(TTM)-108.33M
Analysts44
Price Target12.19 (23.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.81%
PT rev (3m)-21.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.86%
EPS NY rev (3m)-138.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)-8.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.16 | ||
| P/FCF | 2.8 | ||
| P/OCF | 1.54 | ||
| P/B | 0.47 | ||
| P/tB | 0.61 | ||
| EV/EBITDA | 4.77 |
EPS(TTM)-8.5
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)3.52
FCFY35.73%
OCF(TTM)6.42
OCFY65.13%
SpS62.22
BVpS21.12
TBVpS16.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% | ||
| FCFM | 5.66% |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.11%
ROCE(5y)4.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Debt/EBITDA | 5.29 | ||
| Cap/Depr | 22.55% | ||
| Cap/Sales | 4.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 109.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.58 |
F-Score4
WACC6.02%
ROIC/WACCN/A
Cap/Depr(3y)65.96%
Cap/Depr(5y)64.56%
Cap/Sales(3y)6.22%
Cap/Sales(5y)6.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-277.86%
EBIT growth 3Y-42.67%
EBIT growth 5Y-28.34%
EBIT Next Year317.55%
EBIT Next 3Y81.45%
EBIT Next 5YN/A
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y-0.16%
OCF growth 3Y38.62%
OCF growth 5Y-7.61%
GUERBET / GBT.PA Fundamental Analysis FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.
Can you provide the profitability details for GUERBET?
GUERBET (GBT.PA) has a profitability rating of 2 / 10.
Can you provide the financial health for GBT stock?
The financial health rating of GUERBET (GBT.PA) is 3 / 10.
Can you provide the expected EPS growth for GBT stock?
The Earnings per Share (EPS) of GUERBET (GBT.PA) is expected to decline by -417.31% in the next year.